Holen Sie sich die Stockscreener-App
4.60
2.45%
0.11
Handel nachbörslich:
4.58
-0.02
-0.43%
Schlusskurs vom Vortag:
$4.49
Offen:
$4.49
24-Stunden-Volumen:
3.64M
Relative Volume:
0.51
Marktkapitalisierung:
$2.44B
Einnahmen:
$2.21B
Nettoeinkommen (Verlust:
$-56.94M
KGV:
-40.93
EPS:
-0.1124
Netto-Cashflow:
$54.54M
1W Leistung:
-3.36%
1M Leistung:
-4.56%
6M Leistung:
+127.72%
1J Leistung:
+78.99%
1-Tages-Spanne:
$4.45
$4.635
1-Wochen-Bereich:
$4.3401
$4.79
52-Wochen-Spanne:
$1.58
$5.59
Clover Health Investments Corp Stock (CLOV) Company Profile
Firmenname
Clover Health Investments Corp
Sektor
Branche
Telefon
(201) 432-2133
Adresse
30 MONTGOMERY STREET, JERSEY CITY
Compare CLOV vs UNH, CVS, ELV, CI, HUM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLOV
Clover Health Investments Corp
|
4.60 | 2.41B | 2.21B | -56.94M | 54.54M | -0.1124 |
UNH
Unitedhealth Group Inc
|
401.73 | 364.06B | 450.13B | 14.91B | 23.62B | 15.55 |
CVS
Cvs Health Corp
|
97.16 | 121.14B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
400.32 | 86.56B | 201.11B | 4.95B | 6.29B | 22.50 |
CI
Cigna Group
|
282.56 | 73.30B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
389.05 | 46.69B | 137.20B | 1.15B | 1.27B | 9.3439 |
Clover Health Investments Corp Stock (CLOV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-17 | Eingeleitet | Craig Hallum | Buy |
| 2024-10-07 | Eingeleitet | UBS | Neutral |
| 2022-02-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-02-02 | Hochstufung | Cowen | Underperform → Market Perform |
| 2022-01-19 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2022-01-10 | Fortgesetzt | Citigroup | Neutral |
| 2022-01-07 | Herabstufung | Credit Suisse | Neutral → Underperform |
| 2021-09-10 | Eingeleitet | Cowen | Underperform |
| 2021-09-02 | Fortgesetzt | Citigroup | Neutral |
| 2021-07-12 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-06-10 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-05-17 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-03-09 | Eingeleitet | Credit Suisse | Neutral |
| 2021-02-02 | Eingeleitet | Citigroup | Buy |
| 2021-02-01 | Eingeleitet | JP Morgan | Neutral |
Alle ansehen
Clover Health Investments Corp Aktie (CLOV) Neueste Nachrichten
Clover Health Investments (NASDAQ:CLOV) Cut to Buy at Wall Street Zen - marketbeat.com
Clover Health Investments, Corp. • Robinhood Token Price, CLOV Price, Live Charts, and Marketcap - Coinbase
Clover Health Investments: Real Turnaround, But Already Priced In (NASDAQ:CLOV) - Seeking Alpha
Clover Health (CLOV) Q2 2026 Earnings Call Transcript - AOL.com
Shareholder in CLOV (CLOV) registers 474,801 shares for potential sale - Stock Titan
Is Clover Health Investments (CLOV) Fairly Valued After A 228% Run? - Yahoo Finance
Clover Health Is Proving Its Profit Model (NASDAQ:CLOV) - Seeking Alpha
Does Clover’s Profit Turn and Raised 2026 Guidance Reshape the Bull Case for CLOV? - Yahoo Finance
The 5 Most Interesting Analyst Questions From Clover Health’s Q2 Earnings Call - Yahoo Finance
Clover Health Investments, Corp. • Robinhood Token (CLOV) Price Prediction for 2026 to 2031 - Bybit
Clover Health Investments, Corp. (CLOV) Presents at Canaccord Genuity's 46th Annual Growth ConferenceSlideshow - Seeking Alpha
About Clover Health Investments, Corp. • Robinhood Token - Coinbase
Clover Health Interim CFO Joseph Clay Thornton Awarded 54,347 RSUs with Four-Year Vesting - Kalkine Media
Clover Health Investments, Corp. • Robinhood Token (CLOV) Price, MarketCap, Charts and Fundamentals Info - beincrypto.com
Clover Health Eyes 2026 GAAP Profit as AI Platform Fuels Medicare Advantage Growth - marketbeat.com
Clover Health Investments (NASDAQ:CLOV) Shares Down 4.7% After Insider Selling - marketbeat.com
Clover Health at Canaccord Genuity conference: growth meets profit - Investing.com
Clover Health CEO Andrew Toy sells $408,260 in stock By Investing.com - Investing.com Canada
Clover Health CEO Andrew Toy sells $408,260 in stock - Investing.com
Clover Health Investments (NASDAQ:CLOV) CEO Andrew Toy Sells 87,798 Shares - marketbeat.com
Clover Health (CLOV) CEO Andrew Toy sells 87,798 shares for tax withholding - Stock Titan
CLOV (Nasdaq: CLOV) discloses planned 85,704-share sale by Andrew Toy - Stock Titan
Clover Health releases transcript of Q2 2026 earnings call - Bitget
Clover Health Investments : 2Q26 Earnings Call Transcript - marketscreener.com
Clover Health Earnings Call Signals Profitable Growth - TipRanks
Clover Health (CLOV) Is Up 14.1% After Raising 2026 Profit Outlook And Returning To Net Income - simplywall.st
Clover Health Investments (NASDAQ:CLOV) Raised to "Strong-Buy" at Wall Street Zen - marketbeat.com
CLOV SWOT Analysis: Financial Resilience and Growth Potential Re - GuruFocus
Clover Health (NASDAQ: CLOV) holder files Form 144 for major stock sales - Stock Titan
Clover stock seeks strong conclusion to week - Nashville Post
Clover Health Investments, Corp. 2Q 2026: Revenue $743.2M, EPS $0.05— 10-Q Summary - TradingView
3 Growth Companies With Insider Ownership Up To 21% - simplywall.st
CLOV Maintained by UBS -- Price Target Raised to $5.00 - GuruFocus
Clover Health Investments (NASDAQ:CLOV) Shares Gap UpHere's Why - MarketBeat
Clover Health Investments, Corp. Q2 2026 Earnings Call Summary - Yahoo Finance
Renaissance Technologies LLC Sells 1,089,600 Shares of Clover Health Investments, Corp. $CLOV - MarketBeat
Clover Health Investments Corp (CLOV) (Q2 2026) Earnings Call Hi - GuruFocus
CLOV Looks 0.9% Overvalued on GF Value™ - GuruFocus
Clover Health Investments Corp (CLOV) (Q2 2026) Earnings Call Highlights: Strong Revenue Beat ... - Yahoo Finance
Earnings call transcript: Clover Health tops Q2 2026 forecasts, shares jump after hours - Investing.com
Clover Health Investments, Corp. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:CLOV) 2026-08-05 - Seeking Alpha
Clover Health Investments Q2 Earnings Call Highlights - MarketBeat
Is Clover Health Investments Corp (CLOV) Resilient After Q2 Earn - GuruFocus
Clover Health Investments (NASDAQ:CLOV) Posts Quarterly Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat
Clover Health Q2 2026 slides: AI-driven model scales profitability - Investing.com
Clover Health Q2 2026 slides: AI model drives profit surge, guidance up - Investing.com
Clover Health Investments, Corp. reports results for the quarter ended June 30Earnings Summary - tradingview.com
Clover Health Investments earnings beat by $0.01, revenue topped estimates By Investing.com - Investing.com
Clover Health posts Q2 2026 GAAP net income of $28M, revenues $743.2M; raises 2026 guidance - TradingView
Press Release: Clover Health Reports Second Quarter 2026 Results - Moomoo
Clover Health earnings ahead as profitability questions loom By Investing.com - Investing.com Nigeria
Finanzdaten der Clover Health Investments Corp-Aktie (CLOV)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.71%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):